A new an­a­lyst re­port spot­lights 3 more deaths, ARIA among Alzheimer's pa­tients tak­ing Aduhelm

A promi­nent Wall Street an­a­lyst is delv­ing back in­to the agency’s ad­verse event data­base, iden­ti­fy­ing 3 ad­di­tion­al deaths among pa­tients tak­ing the con­tro­ver­sial Alzheimer’s drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER